Secondary |
Drug Use For Unknown Indication |
48.5% |
Product Used For Unknown Indication |
13.8% |
Hypertension |
3.6% |
Depression |
3.2% |
Pain |
2.9% |
Insomnia |
2.8% |
Epilepsy |
2.7% |
Suicide Attempt |
2.7% |
Asthma |
2.6% |
Chronic Obstructive Pulmonary Disease |
2.3% |
Anticoagulant Therapy |
2.0% |
Diabetes Mellitus |
1.8% |
Herpes Zoster |
1.8% |
Prostate Cancer |
1.6% |
Rheumatoid Arthritis |
1.6% |
Hepatitis C |
1.5% |
Acquired Immunodeficiency Syndrome |
1.1% |
Hiv Infection |
1.1% |
Immunosuppressant Drug Therapy |
1.1% |
Influenza |
1.1% |
|
Respiratory Arrest |
13.0% |
Cardio-respiratory Arrest |
9.8% |
Completed Suicide |
7.9% |
Liver Disorder |
7.9% |
Pyrexia |
7.9% |
Toxic Epidermal Necrolysis |
7.9% |
Death |
6.5% |
Drug Toxicity |
5.6% |
Tremor |
4.7% |
Rash |
4.2% |
Vomiting |
3.7% |
Renal Failure |
3.3% |
Suicide Attempt |
2.8% |
Oculomucocutaneous Syndrome |
2.3% |
Pulmonary Oedema |
2.3% |
Somnolence |
2.3% |
Toxicity To Various Agents |
2.3% |
Lower Respiratory Tract Infection |
1.9% |
Nausea |
1.9% |
Pulmonary Embolism |
1.9% |
|
Concomitant |
Drug Use For Unknown Indication |
19.7% |
Hypertension |
9.3% |
Product Used For Unknown Indication |
9.3% |
Depression |
6.4% |
Herpes Zoster |
5.8% |
Asthma |
4.7% |
Pain |
4.5% |
Diabetes Mellitus |
4.1% |
Prophylaxis |
4.1% |
Insomnia |
4.1% |
Constipation |
3.4% |
Infection Prophylaxis |
3.4% |
Rheumatoid Arthritis |
2.8% |
Thrombosis Prophylaxis |
2.8% |
Acquired Immunodeficiency Syndrome |
2.8% |
Breast Cancer |
2.7% |
Gastritis |
2.6% |
Epilepsy |
2.5% |
Chronic Obstructive Pulmonary Disease |
2.4% |
Contraception |
2.4% |
|
Vomiting |
15.1% |
White Blood Cell Count Increased |
8.1% |
Weight Increased |
7.5% |
Weight Decreased |
6.4% |
Renal Failure Acute |
5.9% |
Pyrexia |
5.3% |
Pneumonia |
5.2% |
Restlessness |
4.4% |
Tremor |
4.0% |
Somnolence |
3.8% |
Syncope |
3.8% |
Nausea |
3.7% |
Suicide Attempt |
3.7% |
Neuroleptic Malignant Syndrome |
3.6% |
Renal Failure |
3.6% |
Stevens-johnson Syndrome |
3.4% |
Pulmonary Embolism |
3.3% |
Sepsis |
3.0% |
Thrombocytopenia |
3.0% |
Visual Impairment |
3.0% |
|
Interacting |
Drug Use For Unknown Indication |
50.0% |
Arthralgia |
16.7% |
Nail Tinea |
16.7% |
Nasopharyngitis |
16.7% |
|
Rash |
60.0% |
Muscular Weakness |
40.0% |
|